Skip to product information
1 of 3

STIM1 Recombinant Rabbit mAb (S-6524)

STIM1 Recombinant Rabbit mAb (S-6524)

Catalog Number: S0B60826 Application: WB Reactivity: Hu, Ms, Mk Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen STIM1
Location Cytoplasm, Cytoskeleton, Cell membrane, Endoplasmic reticulum membrane
Accession Q13586
Clone Number S-6524
Antibody Type Recombinant mAb
Isotype IgG
Application WB
Reactivity Hu, Ms, Mk
Positive Sample PANC-1, K-562, HeLa, NIH/3T3, A20, RAW 264.7, COS-7
Predicted Reactivity Rt
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000 Hu, Ms, Mk

Background

STIM1 (stromal interaction molecule 1) is a single-pass transmembrane calcium sensor protein localized to the endoplasmic reticulum (ER) membrane that serves as the core initiator of store-operated calcium entry (SOCE), responsible for sensing depletion of ER luminal calcium stores and transmitting this signal to the Orai1 calcium channels on the plasma membrane. Its luminal N-terminus contains EF-hand and SAM domains, which maintain an autoinhibited conformation through EF-hand–SAM interactions when stores are replete; upon store depletion and calcium dissociation, EF-SAM oligomerizes, and the cytosolic coiled-coil domains then drive STIM1 to form puncta at ER–plasma membrane contact sites, where it directly binds and activates Orai1 channels via the SOAR/CAD domain. In the resting state, STIM1 activity is cooperatively restrained by multiple weak inhibitory interactions, including steric occlusion by the calcium-bound EF-SAM, exchange interactions between CC1α1 and CC3, electrostatic lipid interactions between the CAD tip and the ER membrane, and hydrophobic and electrostatic constraints from CC1α2/3; disruption of any one of these restraints can lead to spontaneous STIM1 activation. Clinically, biallelic loss-of-function mutations in STIM1 cause severe immunodeficiency with hypotonia and autoimmune manifestations, whereas gain-of-function mutations cause tubular aggregate myopathy and Stormorken syndrome, characterized by muscle weakness, thrombocytopenia, asplenia, and short stature.

Picture

Western Blot

WB result of STIM1 Recombinant Rabbit mAb
Primary antibody: STIM1 Recombinant Rabbit mAb at 1/1000 dilution
Primary antibody incubation conditions: overnight at 4°C
Lane 1: PANC-1 whole cell lysate 20 µg
Lane 2: K-562 whole cell lysate 20 µg
Lane 3: HeLa whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 77 kDa
Observed MW: 95 kDa

WB result of STIM1 Recombinant Rabbit mAb
Primary antibody: STIM1 Recombinant Rabbit mAb at 1/1000 dilution
Primary antibody incubation conditions: overnight at 4°C
Lane 1: NIH/3T3 whole cell lysate 20 µg
Lane 2: A20 whole cell lysate 20 µg
Lane 3: RAW 264.7 whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 77 kDa
Observed MW: 90 kDa

WB result of STIM1 Recombinant Rabbit mAb
Primary antibody: STIM1 Recombinant Rabbit mAb at 1/1000 dilution
Primary antibody incubation conditions: overnight at 4°C
Lane 1: COS-7 whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 77 kDa
Observed MW: 90 kDa